LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

LifeMD, Inc.NASDAQ: LFMD

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin narrows to -17.7%

Net margin was -17.7% in Q1 FY2026, down 19.8 pp from a year earlier. On a trailing-twelve-month basis it was -7.4%, down 3.0 pp year over year. Over 3 fiscal years it widened by 34.6 pp.

Context

  • Net margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 5 analysts of -13.9% for the fiscal year ending Dec 2026, down from -3.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-17.7%-14.5 pp QoQ
Last fiscal yearDec 2025
-3.7%+5.2 pp YoY
LTMMar 2026
-7.4%-3.0 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-19.8 pp-10.9 pp+8.8 pp
1 year+5.2 pp-10.3 pp-15.5 pp
3 years+34.6 pp+3.2 pp-31.4 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-3.7%
Year-over-year change
+5.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How LFMD compares with its peers on the latest reported figures

  • LFMD's LTM Mar 2026 net margin of -7.4% is the 4th highest of the 10 companies compared; the peer median is -41.1%.
  • Its year-over-year change of -3.0 pp is the 7th highest of 10, against a peer median of +6.1 pp.
  • Over three fiscal years its change of +34.6 pp compares with a peer median of +11.6 pp.
LFMD Competitors Peer median
Net Margin for LFMD and competitors
Company Period LTM level YoY 3-year change
TBRGTruBridge, Inc.LTM Mar 20261.3% +6.1 pp-3.6 pp
CERSCerus CorporationLTM Mar 2026-4.3% +5.9 pp+18.8 pp
HITIHigh Tide Inc.LTM Apr 2026-6.6% -4.8 pp+11.6 pp
LFMDLifeMD, Inc.LTM Mar 2026-7.4% -3.0 pp+34.6 pp
SMTISanara MedTech Inc.LTM Mar 2026-31.2% -18.8 pp-19.1 pp
TKNOAlpha Teknova, Inc.LTM Mar 2026-41.1% +19.8 pp+72.0 pp
SGHTSight Sciences, Inc.LTM Mar 2026-46.8% +16.4 pp+71.2 pp
MASS908 Devices Inc.LTM Mar 2026-62.1% -30.8 pp+6.4 pp
CVRXCVRx, Inc.LTM Mar 2026-89.1% +8.3 pp+90.3 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-214.2% +98.3 pp-1063.2 pp
Peer median (excluding LFMD) -41.1%+6.1 pp+11.6 pp

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue92.88M119.03M152.55M212.45M194.06M
Cost of Revenue18M18.67M18.9M24.07M39.29M
Gross Profit74.88M100.37M133.65M188.39M154.76M
Gross Margin80.6%84.3%87.6%88.7%79.8%
Research & Development948.16K2.97M6.06M9.51M7.35M
Selling, General & Admin122.08M125.33M128.15M175.68M144.01M
Operating Expenses129.18M143.81M148.14M204.53M162.43M
Depreciation & Amortization355.87K1.09M6.6M9.49M7.31M
EBITDA(57.94M)(38.6M)(8.21M)(6.65M)(1.52M)
EBITDA Margin-62.4%-32.4%-5.4%-3.1%-0.8%
Operating Income(54.3M)(43.45M)(14.49M)(16.14M)(7.67M)
Operating Margin-58.5%-36.5%-9.5%-7.6%-4.0%
Interest Income00000
Interest Expense3.02M1.28M2.6M2.18M1.36M
Other Income / Expenses(7.02M)(1.21M)(2.92M)(2.18M)(2.52M)
Income Before Tax(61.32M)(44.66M)(17.41M)(18.33M)(10.19M)
Pre-Tax Margin-66.0%-37.5%-11.4%-8.6%-5.2%
Income Tax Expense7.7K360.7K428K402K45.72K
Net Income(60.9M)(45.54M)(20.6M)(18.88M)(7.11M)
Net Margin-65.6%-38.3%-13.5%-8.9%-3.7%
EPS (Basic)(2.27)(1.57)(0.70)(0.53)(0.23)
EPS (Diluted)(2.27)(1.57)(0.70)(0.53)(0.23)
Weighted Avg Shares27.01M30.98M33.91M41.2M45.13M
Weighted Avg Shares (Diluted)27.01M30.98M33.91M41.2M45.13M

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.